Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics of AMG 827 in Adolescents With Asthma [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating safety, tolerability, and pharmacokinetics of AMG 827 in adolescents with asthma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• AMG 827

Snippet

Sponsor: Amgen | Conditions: Asthma | Phase 1 | Status: WITHDRAWN